Lunginnov
Lille
About Lunginnov
Lunginnov develops, produces and markets laboratory reagents (monoclonal antibodies, recombinant proteins, ELISA kits, etc. ) to detect and study endothelial dysfunctions.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Last round: Non-Equity Assistance (Dec 2009)
- Website: lunginnov.com
- Phone: 33 3 20 87 72 11
Industries & Categories
Biotechnology
Social Profiles
Canonical: https://fsome.com/organization/lunginnov-504639 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.